Gastric Motility Disorder Drug Market Expected to Expand at a Steady 2024-2031 | Pfizer Inc, AbbVie Inc, Evoke Pharma
Gastric motility disorder drug market is estimated to be valued at USD 57.65 Bn in 2024 and exhibiting a CAGR of 5.4% from 2024 to 2031. BURLINGAME, CALIFORNIA, UNITED STATES, May 8, 2024 /EINPresswire.com/ -- The latest research study released …